ArticleFrontiers in medicine2025
Predicting the invasiveness of pulmonary adenocarcinoma using intratumoral and peritumoral radiomics features.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the predictive value of CT radiomics features within and surrounding tumors in determining the invasiveness of primary solitary nodular pulmonary adenocarcinoma. Methods: This retrospective study analyzed 107 patients with pathologically confirmed nodular pulmonary adenocarcinoma who underwent conventional non-enhanced CT Scans in our hospital from 2019 to 2023. Patients were categorized as non-invasive or invasive based on pathology findings. Clinical and imaging data from both groups were collected and compared, and logistic regression was used to independent factors associated with invasiveness. Radiologists manually outlined 3-dimensional regions of intratumoral and peritumoral areas to extract radiomics features, creating separate intratumor, peritumor, and combined intra-peritumor radiomics models. Radiomics models were trained using LASSO with 10-fold cross-validation in training dataset. Additionally, integrated models combining radiomics with clinical data were developed: intratumor-clinical, peritumor-clinical, and an intra-peri-clinical models. Results: Of the 107 patients, 73 were in the non-invasive group (mean age 49.73 ± 13.92, 22 males) and 34 were in the invasive group (mean age 57.53 ± 12, 14 males). The clinical model identified average nodule diameter and vascular type as independent risk factors for invasiveness (both Conclusion: The combined model incorporating intratumor and peritumor radiomics features with clinical data showed significant value in predicting the invasiveness of nodular pulmonary adenocarcinoma, aiding in the precise selection of surgical methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.